Medpace Stock Price, News & Analysis (NASDAQ:MEDP)

$34.88 0.12 (0.35 %)
(As of 12/11/2017 02:43 AM ET)
Previous Close$34.76
Today's Range$34.30 - $35.08
52-Week Range$21.76 - $39.64
Volume148,500 shs
Average Volume187,707 shs
Market Capitalization$1.31 billion
P/E Ratio23.73
Dividend YieldN/A
BetaN/A

About Medpace (NASDAQ:MEDP)

Medpace logoMedpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Receive MEDP News and Ratings via Email

Sign-up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:MEDP
CUSIPN/A
Phone+1-513-5799911

Debt

Debt-to-Equity Ratio0.36%
Current Ratio0.68%
Quick Ratio0.68%

Price-To-Earnings

Trailing P/E Ratio23.73
Forward P/E Ratio23.25
P/E Growth1.79

Sales & Book Value

Annual Sales$421.58 million
Price / Sales3.11
Cash Flow$2.77 per share
Price / Cash12.57
Book Value$15.00 per share
Price / Book2.33

Profitability

Trailing EPS$0.69
Net Income$13.42 million
Net Margins6.44%
Return on Equity10.00%
Return on Assets6.19%

Miscellaneous

Employees2,500
Outstanding Shares37,580,000

Medpace (NASDAQ:MEDP) Frequently Asked Questions

What is Medpace's stock symbol?

Medpace trades on the NASDAQ under the ticker symbol "MEDP."

How were Medpace's earnings last quarter?

Medpace Holdings Inc (NASDAQ:MEDP) released its quarterly earnings results on Monday, October, 30th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The business had revenue of $98.68 million for the quarter, compared to analysts' expectations of $96.84 million. Medpace had a net margin of 6.44% and a return on equity of 10.00%. The company's revenue was up 4.1% compared to the same quarter last year. During the same period last year, the business earned $0.40 EPS. View Medpace's Earnings History.

When will Medpace make its next earnings announcement?

Medpace is scheduled to release their next quarterly earnings announcement on Monday, February, 26th 2018. View Earnings Estimates for Medpace.

Where is Medpace's stock going? Where will Medpace's stock price be in 2017?

7 Wall Street analysts have issued 1-year price objectives for Medpace's stock. Their predictions range from $34.00 to $38.00. On average, they anticipate Medpace's stock price to reach $35.75 in the next twelve months. View Analyst Ratings for Medpace.

What are Wall Street analysts saying about Medpace stock?

Here are some recent quotes from research analysts about Medpace stock:

  • 1. According to Zacks Investment Research, "Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. " (11/14/2017)
  • 2. Jefferies Group LLC analysts commented, "Medpace boasts eye-popping margin, strong cash flow, and an enticing correlation to fast growing biotech customers. With its group-high valuation, MEDP's risk, in our view, is that investors have looked through management's "conservative" guidance to upsides, akin to prior CRO post-IPO performances. 1.05x BtB, lower 2017 revenue guidance, and in-line EPS will likely pressure the stock a little on Tuesday." (2/28/2017)

Who are some of Medpace's key competitors?

Who are Medpace's key executives?

Medpace's management team includes the folowing people:

  • August J. Troendle M.D., Chairman of the Board, President, Chief Executive Officer (Age 60)
  • Jesse J. Geiger CPA, Chief Financial Officer, Chief Operating Officer - Laboratory Operations (Age 42)
  • Susan E. Burwig, Executive Vice President - Operations (Age 54)
  • Penelope J. Bucknell, Vice President - Human Resources (Age 58)
  • Stephen P. Ewald J.D., General Counsel, Corporate Secretary (Age 47)
  • Anastasya Molodykh, Director
  • John R. Richardson, Director
  • Bruce Brown, Independent Director (Age 59)
  • Brian T. Carley, Independent Director (Age 63)
  • Robert O. Kraft, Independent Director (Age 47)

When did Medpace IPO?

(MEDP) raised $150 million in an initial public offering (IPO) on Thursday, August 11th 2016. The company issued 7,000,000 shares at a price of $20.00-$23.00 per share. Jefferies, Credit Suisse, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Baird and William Blair were co-managers.

Who owns Medpace stock?

Medpace's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Ameriprise Financial Inc. (1.11%), Granite Investment Partners LLC (0.79%), Fisher Asset Management LLC (0.33%), OxFORD Asset Management LLP (0.26%), Prudential Financial Inc. (0.19%) and Russell Investments Group Ltd. (0.10%). Company insiders that own Medpace stock include August J Troendle, Medpace Limited Partnership and Susan E Burwig. View Institutional Ownership Trends for Medpace.

Who sold Medpace stock? Who is selling Medpace stock?

Medpace's stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Prudential Financial Inc., Osborn Williams & Donohoe LLC and California State Teachers Retirement System. View Insider Buying and Selling for Medpace.

Who bought Medpace stock? Who is buying Medpace stock?

Medpace's stock was acquired by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., Fisher Asset Management LLC, Russell Investments Group Ltd., GSA Capital Partners LLP, OxFORD Asset Management LLP, Granite Investment Partners LLC, Citadel Advisors LLC and American Century Companies Inc.. Company insiders that have bought Medpace stock in the last two years include August J Troendle and Susan E Burwig. View Insider Buying and Selling for Medpace.

How do I buy Medpace stock?

Shares of Medpace can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medpace's stock price today?

One share of Medpace stock can currently be purchased for approximately $34.88.

How big of a company is Medpace?

Medpace has a market capitalization of $1.31 billion and generates $421.58 million in revenue each year. The company earns $13.42 million in net income (profit) each year or $0.69 on an earnings per share basis. Medpace employs 2,500 workers across the globe.

How can I contact Medpace?

Medpace's mailing address is 5375 Medpace Way, CINCINNATI, OH 45227-1543, United States. The company can be reached via phone at +1-513-5799911 or via email at [email protected]


MarketBeat Community Rating for Medpace (MEDP)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  79 (Vote Outperform)
Underperform Votes:  92 (Vote Underperform)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about Medpace and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Medpace (NASDAQ:MEDP) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.142.142.502.50
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $35.75$35.75$34.00$32.63
Price Target Upside: 4.59% downside4.59% downside14.48% upside16.89% upside

Medpace (NASDAQ:MEDP) Consensus Price Target History

Price Target History for Medpace (NASDAQ:MEDP)

Medpace (NASDAQ:MEDP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/1/2017Jefferies GroupBoost Price TargetHold$34.00 -> $38.00N/AView Rating Details
11/1/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
10/31/2017Robert W. BairdBoost Price TargetNeutral$32.00 -> $35.00N/AView Rating Details
10/17/2017KeyCorpReiterated RatingHoldN/AView Rating Details
9/29/2017Raymond James FinancialInitiated CoverageMkt Perform -> Market PerformLowView Rating Details
6/6/2017Credit Suisse GroupReiterated RatingOutperform$35.00 -> $36.00LowView Rating Details
5/3/2017Wells Fargo & CompanyDowngradeOutperform -> Market PerformHighView Rating Details
(Data available from 12/11/2015 forward)

Earnings

Medpace (NASDAQ:MEDP) Earnings History and Estimates Chart

Earnings by Quarter for Medpace (NASDAQ:MEDP)

Medpace (NASDAQ MEDP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018$0.38N/AView Earnings Details
10/30/2017Q3 2017$0.36$0.40$96.84 million$98.68 millionViewN/AView Earnings Details
7/31/2017Q2 2017$0.30$0.38$92.71 million$94.60 millionViewN/AView Earnings Details
5/1/2017Q1 2017$0.37$0.34$93.61 million$93.80 millionViewListenView Earnings Details
2/27/2017Q416$0.34$0.35$94.40 million$95.38 millionViewListenView Earnings Details
11/3/2016Q316$0.34$0.40$91.42 million$94.80 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Medpace (NASDAQ:MEDP) Earnings Estimates

2017 EPS Consensus Estimate: $1.41
2018 EPS Consensus Estimate: $1.71
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.38$0.38$0.38
Q2 20173$0.29$0.30$0.30
Q3 20173$0.35$0.36$0.36
Q4 20173$0.37$0.38$0.38
Q1 20183$0.39$0.41$0.40
Q2 20183$0.42$0.43$0.42
Q3 20183$0.43$0.44$0.44
Q4 20183$0.44$0.46$0.45
Q1 20191$0.45$0.45$0.45
Q2 20191$0.46$0.46$0.46
Q3 20191$0.50$0.50$0.50
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Medpace (NASDAQ:MEDP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Medpace (NASDAQ MEDP) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 25.80%
Institutional Ownership Percentage: 16.80%
Insider Trades by Quarter for Medpace (NASDAQ:MEDP)
Insider Trades by Quarter for Medpace (NASDAQ:MEDP)

Medpace (NASDAQ MEDP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/5/2017Medpace Limited PartnershipMajor ShareholderSell4,600,000$30.16$138,736,000.00View SEC Filing  
8/22/2017Medpace Limited PartnershipMajor ShareholderSell2,000,000$30.27$60,540,000.00View SEC Filing  
8/18/2016August J TroendleCEOBuy10,000$27.98$279,800.00View SEC Filing  
8/17/2016Susan E BurwigInsiderBuy19,211$29.21$561,153.31View SEC Filing  
8/16/2016August J TroendleCEOBuy869,565$23.00$19,999,995.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Medpace (NASDAQ MEDP) News Headlines

Source:
DateHeadline
Medpace (MEDP) Downgraded to "Sell" at BidaskClubMedpace (MEDP) Downgraded to "Sell" at BidaskClub
www.americanbankingnews.com - December 11 at 12:52 AM
$0.38 Earnings Per Share Expected for Medpace Holdings Inc (MEDP) This Quarter$0.38 Earnings Per Share Expected for Medpace Holdings Inc (MEDP) This Quarter
www.americanbankingnews.com - December 9 at 11:28 AM
Medpace Holdings Inc (MEDP) Major Shareholder Medpace Limited Partnership Sells 4,600,000 SharesMedpace Holdings Inc (MEDP) Major Shareholder Medpace Limited Partnership Sells 4,600,000 Shares
www.americanbankingnews.com - December 7 at 5:28 PM
Free Post Earnings Research Report: Medpace’ EPS Soared 92%Free Post Earnings Research Report: Medpace’ EPS Soared 92%
finance.yahoo.com - December 5 at 9:50 AM
Medpace Holdings, Inc. (MEDP) Receives Consensus Rating of "Hold" from BrokeragesMedpace Holdings, Inc. (MEDP) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - December 1 at 6:15 AM
Medpace Holdings, Inc. breached its 50 day moving average in a Bearish Manner : MEDP-US : November 30, 2017Medpace Holdings, Inc. breached its 50 day moving average in a Bearish Manner : MEDP-US : November 30, 2017
finance.yahoo.com - November 30 at 9:19 AM
Medpace Holdings (MEDP) Announces 4M Share Secondary OfferingMedpace Holdings (MEDP) Announces 4M Share Secondary Offering
www.streetinsider.com - November 28 at 10:08 AM
Medpace Holdings, Inc. Announces Commencement of Proposed Secondary Offering of Common Stock by Selling ShareholderMedpace Holdings, Inc. Announces Commencement of Proposed Secondary Offering of Common Stock by Selling Shareholder
finance.yahoo.com - November 27 at 4:58 PM
Medpace Holdings, Inc. (MEDP) Stock Rating Lowered by Zacks Investment ResearchMedpace Holdings, Inc. (MEDP) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - November 25 at 10:12 PM
$97.43 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter$97.43 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter
www.americanbankingnews.com - November 23 at 10:22 AM
Zacks: Brokerages Expect Medpace Holdings, Inc. (MEDP) to Post $0.38 EPSZacks: Brokerages Expect Medpace Holdings, Inc. (MEDP) to Post $0.38 EPS
www.americanbankingnews.com - November 21 at 1:26 PM
ETFs with exposure to Medpace Holdings, Inc. : November 17, 2017ETFs with exposure to Medpace Holdings, Inc. : November 17, 2017
finance.yahoo.com - November 17 at 3:57 PM
Medpace Holdings, Inc. (MEDP) Receives Consensus Recommendation of "Hold" from BrokeragesMedpace Holdings, Inc. (MEDP) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 6 at 3:46 AM
Medpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017Medpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017
finance.yahoo.com - November 3 at 5:18 PM
ETFs with exposure to Medpace Holdings, Inc. : November 3, 2017ETFs with exposure to Medpace Holdings, Inc. : November 3, 2017
finance.yahoo.com - November 3 at 5:18 PM
 Analysts Expect Medpace Holdings, Inc. (MEDP) Will Announce Quarterly Sales of $97.43 Million Analysts Expect Medpace Holdings, Inc. (MEDP) Will Announce Quarterly Sales of $97.43 Million
www.americanbankingnews.com - November 3 at 10:51 AM
Jefferies Group Analysts Raise Earnings Estimates for Medpace Holdings Inc (MEDP)Jefferies Group Analysts Raise Earnings Estimates for Medpace Holdings Inc (MEDP)
www.americanbankingnews.com - November 2 at 8:53 AM
FY2017 EPS Estimates for Medpace Holdings Inc (MEDP) Lifted by William BlairFY2017 EPS Estimates for Medpace Holdings Inc (MEDP) Lifted by William Blair
www.americanbankingnews.com - November 2 at 8:53 AM
Equities Analysts Set Expectations for Medpace Holdings Incs FY2017 Earnings (MEDP)Equities Analysts Set Expectations for Medpace Holdings Inc's FY2017 Earnings (MEDP)
www.americanbankingnews.com - November 2 at 8:52 AM
Analysts Issue Forecasts for Medpace Holdings, Inc.s Q1 2018 Earnings (MEDP)Analysts Issue Forecasts for Medpace Holdings, Inc.'s Q1 2018 Earnings (MEDP)
www.americanbankingnews.com - November 1 at 2:04 PM
William Blair Research Analysts Lift Earnings Estimates for Medpace Holdings, Inc. (MEDP)William Blair Research Analysts Lift Earnings Estimates for Medpace Holdings, Inc. (MEDP)
www.americanbankingnews.com - November 1 at 9:18 AM
Edited Transcript of MEDP earnings conference call or presentation 31-Oct-17 1:00pm GMTEdited Transcript of MEDP earnings conference call or presentation 31-Oct-17 1:00pm GMT
finance.yahoo.com - November 1 at 6:10 AM
Medpace Holdings, Inc. (MEDP) Price Target Raised to $35.00 at Robert W. BairdMedpace Holdings, Inc. (MEDP) Price Target Raised to $35.00 at Robert W. Baird
www.americanbankingnews.com - October 31 at 10:48 AM
Medpace Holdings, Inc. (MEDP) Issues Quarterly  Earnings Results, Beats Estimates By $0.04 EPSMedpace Holdings, Inc. (MEDP) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - October 31 at 8:56 AM
Medpace Holdings, Inc. Reports Third Quarter 2017 ResultsMedpace Holdings, Inc. Reports Third Quarter 2017 Results
finance.yahoo.com - October 31 at 5:16 AM
Medpace beats Street 3Q forecastsMedpace beats Street 3Q forecasts
finance.yahoo.com - October 31 at 5:16 AM
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare ConferenceMedpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
finance.yahoo.com - October 31 at 5:16 AM
Medpace Holdings, Inc. (MEDP) Set to Announce Earnings on WednesdayMedpace Holdings, Inc. (MEDP) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - October 25 at 5:24 AM
$95.30 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter$95.30 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter
www.americanbankingnews.com - October 15 at 1:32 PM
 Brokerages Expect Medpace Holdings, Inc. (MEDP) Will Announce Earnings of $0.36 Per Share Brokerages Expect Medpace Holdings, Inc. (MEDP) Will Announce Earnings of $0.36 Per Share
www.americanbankingnews.com - October 13 at 6:20 AM
Medpace Holdings, Inc. (MEDP) Receives Consensus Rating of "Buy" from AnalystsMedpace Holdings, Inc. (MEDP) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - October 12 at 2:44 AM
FY2017 EPS Estimates for Medpace Holdings, Inc. (MEDP) Lifted by AnalystFY2017 EPS Estimates for Medpace Holdings, Inc. (MEDP) Lifted by Analyst
www.americanbankingnews.com - October 10 at 8:06 AM
How Vantiv helped Cincinnati investment pro rise in stock contestHow Vantiv helped Cincinnati investment pro rise in stock contest
www.bizjournals.com - October 9 at 9:05 PM
Medpace Holdings (MEDP) "Hold" Rating Reiterated at Robert W. BairdMedpace Holdings' (MEDP) "Hold" Rating Reiterated at Robert W. Baird
www.americanbankingnews.com - October 9 at 3:16 PM
Head to Head Review: Medpace Holdings (MEDP) versus Its PeersHead to Head Review: Medpace Holdings (MEDP) versus Its Peers
www.americanbankingnews.com - October 9 at 12:38 PM
Medpace Holdings, Inc. to Report Third Quarter 2017 Financial Results on October 30, 2017Medpace Holdings, Inc. to Report Third Quarter 2017 Financial Results on October 30, 2017
finance.yahoo.com - October 6 at 10:21 AM
Does Medpace Holdings Inc’s (MEDP) PE Ratio Signal A Selling Opportunity?Does Medpace Holdings Inc’s (MEDP) PE Ratio Signal A Selling Opportunity?
finance.yahoo.com - October 2 at 5:20 PM
Medpace Holdings, Inc. (MEDP) Now Covered by Analysts at Raymond James Financial, Inc.Medpace Holdings, Inc. (MEDP) Now Covered by Analysts at Raymond James Financial, Inc.
www.americanbankingnews.com - September 29 at 10:02 AM
PAREXELs Acquisition by Pamplona Approved by Shareholders - NasdaqPAREXEL's Acquisition by Pamplona Approved by Shareholders - Nasdaq
www.nasdaq.com - September 27 at 3:48 PM
 Brokerages Expect Medpace Holdings, Inc. (MEDP) Will Post Earnings of $0.36 Per Share Brokerages Expect Medpace Holdings, Inc. (MEDP) Will Post Earnings of $0.36 Per Share
www.americanbankingnews.com - September 24 at 2:28 PM
Medpace Holdings, Inc. (MEDP) Given Consensus Rating of "Buy" by AnalystsMedpace Holdings, Inc. (MEDP) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - September 17 at 2:50 AM
Medpace Holdings, Inc. (MEDP) Expected to Post Quarterly Sales of $95.10 MillionMedpace Holdings, Inc. (MEDP) Expected to Post Quarterly Sales of $95.10 Million
www.americanbankingnews.com - September 7 at 7:38 AM
BRIEF-Medpace Holdings files for mixed shelf of up to $75 million ‍BRIEF-Medpace Holdings files for mixed shelf of up to $75 million ‍
www.reuters.com - September 2 at 7:36 PM
Medpace Holdings, Inc. to Present at Wells Fargo Healthcare ConferenceMedpace Holdings, Inc. to Present at Wells Fargo Healthcare Conference
finance.yahoo.com - August 24 at 9:08 AM
Medpace Holdings, Inc. (MEDP) Given Average Recommendation of "Hold" by BrokeragesMedpace Holdings, Inc. (MEDP) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 23 at 3:32 AM
Insider Selling: Medpace Holdings, Inc. (MEDP) Major Shareholder Sells 2,000,000 Shares of StockInsider Selling: Medpace Holdings, Inc. (MEDP) Major Shareholder Sells 2,000,000 Shares of Stock
www.americanbankingnews.com - August 22 at 7:16 PM
Medpace Holdings (MEDP) & Voyager Therapeutics (VYGR) Head to Head AnalysisMedpace Holdings (MEDP) & Voyager Therapeutics (VYGR) Head to Head Analysis
www.americanbankingnews.com - August 21 at 10:26 AM
BRIEF-Medpace Holdings announces stock repurchase agreement with CinvenBRIEF-Medpace Holdings announces stock repurchase agreement with Cinven
www.reuters.com - August 18 at 6:42 AM
ETFs with exposure to Medpace Holdings, Inc. : August 16, 2017ETFs with exposure to Medpace Holdings, Inc. : August 16, 2017
finance.yahoo.com - August 17 at 2:32 AM
Medpace Holdings, Inc. Announces Stock Repurchase Agreement with CinvenMedpace Holdings, Inc. Announces Stock Repurchase Agreement with Cinven
finance.yahoo.com - August 17 at 2:32 AM

SEC Filings

Medpace (NASDAQ:MEDP) SEC Filings

DateFilerForm TypeView
12/07/2017
3:07 PM
Cinven Capital Management General Partner Ltd (0001657322) (Filed by)
Medpace (Subject)
Form SC 13D/A
View Filing
12/07/2017
3:05 PM
Cinven Capital Management Limited Partnership Inc (0001677850) (Reporting)
Medpace GP Ltd (Reporting)
Medpace (Issuer)
Medpace Limited Partnership (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/05/2017
3:31 PM
Medpace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/04/2017
3:44 PM
Medpace (Filer)
Form 424B7
View Filing
11/30/2017
8:20 PM
Medpace (Subject)
Form FWP
View Filing
11/30/2017
5:12 AM
Medpace (Subject)
Form FWP
View Filing

Social Media

Financials

Medpace (NASDAQ:MEDP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Medpace (NASDAQ MEDP) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.